Letter: Complications of carbenoxolone therapy.
D004359:Drug Therapy, Combination; D006035:Glycyrrhiza; D006801:Humans; D010946:Plants, Medicinal; D013148:Spironolactone / Q000494:pharmacology; D013386:Succinates / Q000627:therapeutic use; D013729:Terpenes / Q000037:antagonists & inhibitors; D014315:Triterpenes / Q000627:therapeutic use*
D013386:Succinates; D013729:Terpenes; D014315:Triterpenes; D013148:Spironolactone